TY  - RPRT
TI  - Rational design of HER2-targeted combination therapies to reverse drug resistance in fibroblast-protected HER2+ breast cancer cells.
AU  - Poskus, M. D.
AU  - McDonald, J.
AU  - Laird, M.
AU  - Li, R.
AU  - Norcoss, K.
AU  - Zervantonakis, I. K.
PY  - 2024
DO  - 10.1101/2024.05.18.594826
UR  - https://www.biorxiv.org/content/10.1101/2024.05.18.594826v1
ID  - 10.1101/2024.05.18.594826
ER  -